| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY |
|---|---|---|---|
| Revenue | – | – | – |
| Cost of Revenue | – | – | – |
| Gross Profit | – | – | – |
| Operating Expenses | $169.83M | $142.60M | $62.41M |
| R&D | $133.72M | $112.47M | $49.92M |
| SG&A | $36.11M | $30.13M | $12.48M |
| Operating Income | -$169.83M | -$142.60M | -$62.41M |
| Interest Expense | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 |
| Net Income | -$161.31M | -$127.48M | -$60.37M |
| EPS (basic) | -3.6400 | -3.3300 | -89.6100 |
| EPS (diluted) | -3.6400 | -3.3300 | -89.6100 |
| Shares (diluted) | $44.26M | $38.33M | $673.62K |